Dublin, June 23, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, Lubricant, Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" report to their offering.
The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021.
The rising demand for newer & improved drugs, development of new drug delivery systems, and greater understanding of the functional benefits of excipients are positively impacting the overall growth of the market.
In this report, the global pharmaceutical excipients market is mainly segmented by product, by formulation, by functionality, and by region. The market is classified on the basis of product into inorganic chemicals, organic chemicals, and other chemicals. Organic chemicals are further divided into carbohydrates [sugars (lactose, sucrose, maltose, dextrose, sorbitol, mannitol, xylitol, artificial sweeteners, starch, and cellulose)], petrochemicals [glycols (polyethylene glycol, propylene glycol), Povidones, mineral hydrocarbons (petroleum, mineral waxes, mineral oils), acrylic polymers, other petrochemical excipients], oleochemicals (fatty alcohols, mineral stearate, glycerin, and other oleochemical excipients), proteins, and others.
On the basis of formulation, the market is subsegmented into oral formulation, topical formulation, parenteral formulation, and advanced delivery systems. The oral formulation segment, by delivery mode, is subdivided into tablets, capsules, and liquid formulations. By functionality, the pharmaceutical excipients market is divided into fillers & diluents, binders, suspension & viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants & glidants, preservatives, and others.
Oral formulations accounted for largest share of the pharmaceutical excipients market in 2015. Owing to the shrinking pipeline of new chemical entities (NCEs), companies are increasingly focusing on the development of orally disintegrating tablets (ODTs) and other novel methods of oral drug delivery. There is also a growing trend towards the formulation of sachets. The topical formulation segment is expected to register the highest growth during the forecast period of 2016-2021.
In 2015, the organic chemicals segment accounted for the largest market share of pharmaceutical excipients market, followed by inorganic chemicals. The large share of organic chemicals can be attributed to their wide application in the manufacturing of pharmaceutical products.
In 2015, Europe accounted for the largest share of the global pharmaceutical excipients market, followed by North America and Asia-Pacific. The presence of a large number of pharmaceutical drug manufacturers in Europe has led to their large market share in the market. However, the Asia-Pacific region represents the highest growth opportunity for the market during the forecast period of 2016 to 2021.
The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF SE (Germany), the Dow Chemical Company (U.S.), Roquette (France), FMC Corporation (U.S.), Evonik Industries AG (Germany), Associated British Foods Plc. (U.K.), Archer Daniels Midland Company (U.S.), Lubrizol Corporation (U.S.), and Croda International Plc. (U.K.).
For more information visit http://www.researchandmarkets.com/research/s7gqnv/pharmaceutical